Kanada - Ingliż - Health Canada

jamp pharma corporation - ticagrelor - tablet - 60mg - ticagrelor 60mg

Kanada - Ingliż - Health Canada

jamp pharma corporation - ticagrelor - tablet - 90mg - ticagrelor 90mg

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

global medical solutions australia pty limited t/a radpharm scientific - stannous chloride dihydrate, quantity: 0.24 mg; disofenin, quantity: 20 mg - injection, powder for - excipient ingredients: - indications as at 14 may 2003: technetium tc99m disofenin is indicated as an adjunct in the diagnosis of hepatobiliary disease.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

global medical solutions australia pty limited t/a radpharm scientific - bicisate dihydrochloride, quantity: 0.9 mg - injection, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; monobasic sodium phosphate; water for injections - [99mtc]-bicisate scintigraphy is indicated in the evaluation and localisation of regional perfusion abnormalities in adult patients with the central nervous system disorders of stroke and dementia.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

global medical solutions australia pty limited t/a radpharm scientific - tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate, quantity: 1 mg - injection, powder for - excipient ingredients: cysteine hydrochloride; stannous chloride dihydrate; sodium citrate dihydrate; mannitol - technetium (99mtc) sestamibi is indicated for use in conjunction with stress testing as an adjunct in the diagnosis of ischaemic heart disease. in these patients additional information about ventricular function may be derived by using the first pass technique. indications as at 23 november 1999: technetium [99mtc] sestamibi is indicated for use in conjunction with stress testing as an adjunct in the diagnosis of ischaemic heart disease. in these patients additional information about ventricular function may be derived by using the first pass technique. technetium [99mtc] sestamibi is indicated as a second line diagnostic aid to assist in the evaluation of patients for whom mammography is inconclusive.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - cladribine 10mg;   - tablet - 10 mg - active: cladribine 10mg   excipient: hydroxypropyl-beta-cyclodextrin magnesium stearate sorbitol water for injection - mavenclad is indicated for the treatment of relapsing-remitting multiple sclerosis (rrms) to reduce the frequency of clinical relapses and to delay the progression of physical disability. following completion of the two treatment courses, no further cladribine treatment is required in years three and four. re-initiation of therapy after year four has not been studied.

Malasja - Ingliż - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - omeprazole -

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - azacitidine 100mg (105 mg per vial including 5% manufacturing overage) - powder for injection - 100 mg - active: azacitidine 100mg (105 mg per vial including 5% manufacturing overage) excipient: mannitol - indicated for the treatment of patients with: - intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss). - chronic myelomonocytic leukaemia (cmmol [10%-29% marrow blasts without myeloproliferative disorder]). - acute myeloid leukaemia (aml) with 20-30% blasts and multi-lineage dysplasia, according to world health organisation classification, in whom allogenic stem cell transplantation is not indicated.

Singapor - Ingliż - HSA (Health Sciences Authority)

sysmex asia pacific pte. ltd. - hematology - dade pfa collagen/ epi test cartridge and dade pfa collagen/ adp test cartridge are in vitro diagnostic reagents for the quantitative determination of the collagen/epinephrine- and collagen/adp-induced pfa closure times. the assays can be used as aid to diagnosis and follow up of congenital, acquired or therapy induced defects of primary hemostasis, including von willebrand factor (vwf) dependent deficiencies, in patients at risk for or suspected of impaired primary hemostasis. the assays are performed using human sodium citrated whole blood by means of an automated, platelet adhesion and aggregation method under flow conditions.

Indja - Ingliż - Central Drugs Standard Control Organization

caplet ind. - amlodipine - tab - 10mg - 10